Product Information
MOMETASONE FUROATE 0.1% SOLN is a generic product labeled by Encube Ethicals, Inc., priced at $0.4875 per ML under NDC 21922007221. Its NADAC has been published 86 times since Feb 12, 2025.
FDA first approved this application on Nov 21, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/mL
Manufacturer
Encube Ethicals, Inc.NDC
21922007221
Classification
Generic
Dosage Form
LOTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
MOMETASONE FUROATEApproval Type
Generic (ANDA)
FDA Application
ANDA076499FDA Approved
11/21/2007
TE Code
AB
On Market Since
1/22/2025
Pharmacological Classes
Price Statistics
The NADAC for MOMETASONE FUROATE 0.1% SOLN has been published 86 times since Feb 12, 2025, and over the history we have for it it has risen 25.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4875 per ML |
|---|---|
| All-time high | $0.5133 (Dec 10, 2025) |
| All-time low | $0.3883 (Feb 12, 2025) |
| 52-week high | $0.5133 |
| 52-week low | $0.4714 |
| Median price | $0.4935 |
| Average price | $0.4692 |
| Largest weekly change | +8.7% (Sep 17, 2025) |
| Weeks tracked | 86 |
| Tracking since | Feb 12, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Encube Ethicals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
MOMETASONE FUROATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MOMETASONE FUROATE 0.1% SOLN?
The current National Average Drug Acquisition Cost (NADAC) for MOMETASONE FUROATE 0.1% SOLN, manufactured by Encube Ethicals, Inc., is $0.4875 per ML (NDC 21922007221), effective Sep 30, 2026.
How has the price of MOMETASONE FUROATE 0.1% SOLN changed over time?
Over the history we have for it, the NADAC for MOMETASONE FUROATE 0.1% SOLN has risen 25.5%. It has been tracked across 86 weekly CMS publications since Feb 12, 2025.
What are the highest and lowest recorded NADAC prices for MOMETASONE FUROATE 0.1% SOLN?
Since Feb 12, 2025, the NADAC for MOMETASONE FUROATE 0.1% SOLN has ranged from a low of $0.3883 (Feb 12, 2025) to a high of $0.5133 (Dec 10, 2025), with a median of $0.4935 per ML.
Are there cheaper alternatives to MOMETASONE FUROATE 0.1% SOLN?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MOMETASONE FUROATE 0.1% SOLN, is $0.4777 per ML — about 2% below MOMETASONE FUROATE 0.1% SOLN.
Who manufactures MOMETASONE FUROATE 0.1% SOLN?
MOMETASONE FUROATE 0.1% SOLN (NDC 21922007221) is labeled by Encube Ethicals, Inc., and CMS classifies it as a generic product.